Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale
- Posted on December 23, 2025
- By CNBC
- 3 Views
Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale
Club holding Lilly stock slumped 1% Tuesday while Novo Nordisk shares jumped nearly 9%.
